PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 21, 2001New England Journal of Medicine226 citationsOpen Access

Deep Venous Thrombosis and Thalidomide Therapy for Multiple Myeloma

View Full Paper
KOKeren OsmanRCRaymond L. ComenzoSRS. Vincent Rajkumar

Key Points

Key points are not available for this paper at this time.

Abstract

To the Editor: Thalidomide is effective for the treatment of refractory myeloma.1 Its role in the initial treatment of the disease is under active investigation.2,3 We report the occurrence of deep...

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Osman et al. (2001) studied this question.

synapsesocial.com/papers/6a583fe7d848c9ced74cc866https://doi.org/10.1056/nejm200106213442516
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antitumor Activity of Thalidomide in Refractory Multiple Myeloma1999 · 2,602 citations
  2. 2[Thalidomide and thrombosis].2000 · 51 citations
  3. 3Life-Threatening Toxic Epidermal Necrolysis with Thalidomide Therapy for Myeloma2000 · 100 citations
  4. 4The Evolution of B Precursor Leukemia in the Eμ-ret Mouse1998 · 41 citations
  5. 5Bone marrow angiogenesis and progression in multiple myeloma1994 · 644 citations